Human cyclosporiasis.
Giangaspero A, Gasser RB.
Lancet Infect Dis. 2019 Jul;19(7):e226-e236. doi: 10.1016/S1473-3099(18)30789-8. Epub 2019 Mar 15.
Advances in Cyclosporiasis Diagnosis and Therapeutic Intervention.
Li J, Cui Z, Qi M, Zhang L.
Front Cell Infect Microbiol. 2020 Feb 11;10:43. doi: 10.3389/fcimb.2020.00043. eCollection 2020.
Review on Cyclosporiasis Outbreaks and Potential Molecular Markers for Tracing Back Investigations.
Li J, Xu F, Karim MR, Zhang L.
Foodborne Pathog Dis. 2022 Dec;19(12):796-805. doi: 10.1089/fpd.2022.0054. Epub 2022 Nov 25.
Cyclosporiasis-Updates on Clinical Presentation, Pathology, Clinical Diagnosis, and Treatment.
Mathison BA, Pritt BS.
Microorganisms. 2021 Sep 2;9(9):1863. doi: 10.3390/microorganisms9091863.
[Cyclosporiasis].
Hernández-Mora MG, Fortés J, Fernández Guerrero ML.
Med Clin (Barc). 2000 Oct 7;115(11):431-4.
Cyclospora cayetanensis and Cyclosporiasis: An Update.
Almeria S, Cinar HN, Dubey JP.
Microorganisms. 2019 Sep 4;7(9):317. doi: 10.3390/microorganisms7090317.
Parasites.
Theel ES, Pritt BS.
Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.DMIH2-0013-2015.
Cyclosporiasis: an emerging public health concern around the world and in Africa.
Karanja RM, Gatei W, Wamae N.
Afr Health Sci. 2007 Jun;7(2):62-7. doi: 10.5555/afhs.2007.7.2.62.
Cyclosporiasis Surveillance - United States, 2011-2015.
Casillas SM, Hall RL, Herwaldt BL.
MMWR Surveill Summ. 2019 Apr 19;68(3):1-16. doi: 10.15585/mmwr.ss6803a1.
Cyclospora cayetanensis: a review, focusing on some of the remaining questions about cyclosporiasis.
Helmy MM.
Infect Disord Drug Targets. 2010 Oct;10(5):368-75. doi: 10.2174/187152610793180885.
